J.W. Cole Advisors Inc. Sells 4,850 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

J.W. Cole Advisors Inc. decreased its position in shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMTGet Rating) by 22.2% during the 1st quarter, Holdings Channel reports. The fund owned 16,950 shares of the oil and gas company’s stock after selling 4,850 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Calumet Specialty Products Partners were worth $231,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Brown Advisory Inc. boosted its stake in Calumet Specialty Products Partners by 1,788.9% during the 1st quarter. Brown Advisory Inc. now owns 792,581 shares of the oil and gas company’s stock worth $10,787,000 after acquiring an additional 750,621 shares during the last quarter. Raymond James & Associates boosted its stake in Calumet Specialty Products Partners by 15.1% during the 1st quarter. Raymond James & Associates now owns 308,055 shares of the oil and gas company’s stock worth $4,193,000 after acquiring an additional 40,480 shares during the last quarter. UBS Group AG lifted its stake in Calumet Specialty Products Partners by 3.4% in the first quarter. UBS Group AG now owns 97,580 shares of the oil and gas company’s stock valued at $1,328,000 after buying an additional 3,211 shares in the last quarter. PEAK6 Investments LLC lifted its stake in Calumet Specialty Products Partners by 152.9% in the first quarter. PEAK6 Investments LLC now owns 70,757 shares of the oil and gas company’s stock valued at $963,000 after buying an additional 42,784 shares in the last quarter. Finally, Bank of Montreal Can bought a new position in Calumet Specialty Products Partners in the fourth quarter valued at approximately $760,000. Institutional investors own 20.43% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Cowen lifted their price target on shares of Calumet Specialty Products Partners from $18.00 to $20.00 and gave the company an “outperform” rating in a research note on Tuesday, June 28th. The Goldman Sachs Group raised shares of Calumet Specialty Products Partners from a “neutral” rating to a “buy” rating and lifted their price target for the company from $14.00 to $23.00 in a research note on Thursday, August 18th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $25.50.

Insider Activity

In other Calumet Specialty Products Partners news, Chairman Stephen P. Mawer acquired 9,251 shares of the stock in a transaction dated Friday, August 12th. The shares were bought at an average cost of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the acquisition, the chairman now directly owns 137,233 shares of the company’s stock, valued at $2,210,823.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Calumet Specialty Products Partners news, Chairman Stephen P. Mawer acquired 9,251 shares of the stock in a transaction dated Friday, August 12th. The shares were bought at an average cost of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the acquisition, the chairman now directly owns 137,233 shares of the company’s stock, valued at $2,210,823.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Stephen P. Mawer bought 4,321 shares of the stock in a transaction that occurred on Tuesday, August 16th. The shares were purchased at an average price of $16.17 per share, for a total transaction of $69,870.57. Following the completion of the acquisition, the chairman now owns 141,554 shares of the company’s stock, valued at approximately $2,288,928.18. The disclosure for this purchase can be found here. Insiders have acquired 42,268 shares of company stock worth $691,954 over the last ninety days. Insiders own 2.91% of the company’s stock.

Calumet Specialty Products Partners Stock Down 5.5 %

NASDAQ CLMT opened at $15.95 on Thursday. Calumet Specialty Products Partners, L.P. has a 12-month low of $7.34 and a 12-month high of $18.47. The company has a market capitalization of $1.26 billion, a PE ratio of -8.81 and a beta of 2.05. The firm’s 50 day moving average is $15.21 and its 200-day moving average is $13.85.

Calumet Specialty Products Partners Profile

(Get Rating)

Calumet Specialty Products Partners LP engages in the production of specialty hydrocarbon products. It operates through the following segments: Specialty Products, Fuel Products and Corporate. The Specialty Products segment produces lubricating oils, solvents, waxes, synthetic lubricants and other products.

Featured Stories

Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet Specialty Products Partners, L.P. (NASDAQ:CLMTGet Rating).

Institutional Ownership by Quarter for Calumet Specialty Products Partners (NASDAQ:CLMT)

Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.